Immunization News and Research

RSS

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A team of international scientists has developed an mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant. The vaccine candidate has shown high efficacy in inducing neutralizing antibodies and protecting against delta infection in mice. The study is currently available on the bioRxiv* preprint server.

24 Mar 2022

Polio vaccination campaign kicks off in Malawi and neighboring countries

A vaccination campaign targeting 23 million children has kicked off in Malawi and neighboring countries to contain an outbreak of wild polio declared last month, the World Health Organization says.

24 Mar 2022

Study investigates anti-SARS-CoV-2 antibody levels following Pfizer vaccine primary and booster regimens

A new study presented the differences among total anti-SARS-CoV-2 antibodies following SARS-CoV-2 Pfizer primary and booster vaccinations.

24 Mar 2022

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Researchers evaluated the effectiveness of a novel vaccine candidate UB-612 against 14 SARS-CoV-2 variants, including the latest variant of concern, Omicron.

24 Mar 2022

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Researchers evaluated the humoral and cellular immune memory induced by four COVID-19 vaccines representing three different vaccine platforms.

24 Mar 2022

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers compare the impact of a third mRNA COVID-19 vaccine in hemodialysis patients by measuring antibody levels and IFN-γ responses.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

In a new study, researchers discovered human monoclonal antibodies, which were specific and potent against the severe acute respiratory syndrome coronavirus 2 Omicron variant.

23 Mar 2022

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Researchers reported a new monoclonal antibody, P2G3, which significantly neutralized the SARS-CoV-2 Omicron variant.

23 Mar 2022

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

In a new study, researchers explored the germinal center of antibody-mediated immunity towards SARS-CoV-2.

23 Mar 2022

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Researchers report the results for a new SARS-CoV-2 vaccine currently in Phase III clinical trial known as I53-50.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

Immunization News and Research

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

Polio vaccination campaign kicks off in Malawi and neighboring countries

Study investigates anti-SARS-CoV-2 antibody levels following Pfizer vaccine primary and booster regimens

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Characteristics of vaccine hesitancy in England at the community level

Association between seropositivity and comorbidities after COVID-19 vaccination

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Safety and antibody responses to COVID-19 vaccines in an older community

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News